Breaking News Instant updates and real-time market news.

2022-03-24 14:04:18 AZN AstraZeneca $65.50 / +1.18 (+1.83%) 14:04 03/24/22 03/24 14:04 03/24/22 14:04	AstraZeneca reports Evusheld recommended for approval in EU for COVID prevention AstraZeneca's Evusheld, a long-acting antibody combination, has been recommended for marketing authorization in the European Union for the pre-exposure prophylaxis, or prevention, of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg, the company announced. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: "Today's positive CHMP recommendation represents a significant step forward in our ongoing efforts to introduce additional, important preventative measures for people in Europe at higher risk of developing COVID-19. Evusheld has the potential to provide long-lasting protection to vulnerable populations such as the immunocompromised who can't mount an adequate response to a COVID-19 vaccine, and we'll continue to work with governments in Europe to make Evusheld available as quickly as possible." The recommended dose of Evusheld in Europe is 150mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular injections.	31 Mar 08 Apr 03 Jun

2022-03-24 14:04:18

AZN

AstraZeneca

$65.50 / +1.18 (+1.83%)

14:04

03/24/22

03/24

14:04

03/24/22

14:04

AstraZeneca reports Evusheld recommended for approval in EU for COVID prevention

AstraZeneca's Evusheld, a long-acting antibody combination, has been recommended for marketing authorization in the European Union for the pre-exposure prophylaxis, or prevention, of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg, the company announced. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: "Today's positive CHMP recommendation represents a significant step forward in our ongoing efforts to introduce additional, important preventative measures for people in Europe at higher risk of developing COVID-19. Evusheld has the potential to provide long-lasting protection to vulnerable populations such as the immunocompromised who can't mount an adequate response to a COVID-19 vaccine, and we'll continue to work with governments in Europe to make Evusheld available as quickly as possible." The recommended dose of Evusheld in Europe is 150mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular injections.

31
Mar
08
Apr
03
Jun

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Cion Investment announces expansion of Share Repurchase Policy by $10M » 08:09 06/27/22 06/27 08:09 06/27/22 08:09 CION Cion Investment $8.21 / +0.23 (+2.88%) CION Investment announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options CION Cion Investment $8.21 / +0.23 (+2.88%) 05/10/22 Cion and Man Group team with iCapital2 to form JV for alternative strategies CION Cion Investment $8.21 / +0.23 (+2.88%) 11/01/21 Wells Fargo CION Investment initiated with Equal Weight, $12.50 target at Wells Fargo 11/01/21 Wells Fargo CION Investment initiated with an Equal Weight at Wells Fargo CION Cion Investment $8.21 / +0.23 (+2.88%) 05/12/22 Cion Investment reports Q1 NII 34c vs. 31c last year 03/10/22 Cion Investment reports Q2 EPS 28c, two estimates (34c) CION Cion Investment $8.21 / +0.23 (+2.88%) 05/04/22 Fourteen new option listings on May 4th
Hot Stocks	Canadian National to invest $30M in Tennessee in 2022 » 08:09 06/27/22 06/27 08:09 06/27/22 08:09 CNI Canadian National $113.77 / +4.28 (+3.91%) CN announced plans to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CNI Canadian National $113.77 / +4.28 (+3.91%) 08:09 Today Canadian National to invest C$185M in Saskatchewan 06/23/22 CN to invest C$160M in Manitoba in 2022 06/23/22 CN to invest C$15M in Nova Scotia in 2022 06/22/22 North American rail traffic fell 2.8% for the week ending June 18 CNI Canadian National $113.77 / +4.28 (+3.91%) 06/14/22 Deutsche Bank Canadian National named short-term investment idea at Deutsche Bank 06/02/22 CIBC Canadian National upgraded to Outperformer from Neutral at CIBC 05/26/22 Evercore ISI Canadian National upgraded to Outperform from In Line at Evercore ISI 05/19/22 Citi Canadian National price target lowered to $132 from $140 at Citi CNI Canadian National $113.77 / +4.28 (+3.91%) 04/26/22 Canadian National lowers FY22 adjusted EPS view to up 15%-20% from up 20% 04/26/22 Canadian National reports Q1 adjusted EPS C$1.32 vs. C$1.23 last year 01/25/22 Canadian National sees FY22 adjusted EPS up 20% 01/25/22 Canadian National reports Q4 adjusted EPS C$1.71 vs. C$1.43 last year CNI Canadian National $113.77 / +4.28 (+3.91%) 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/22 Fly Intel: After-Hours Movers 07/26/22 Canadian National - CNI CNI Canadian National $113.77 / +4.28 (+3.91%) 01/25/22 Canadian National options imply 3.2% move in share price post-earnings
Hot Stocks	Canadian National to invest C$185M in Saskatchewan » 08:09 06/27/22 06/27 08:09 06/27/22 08:09 CNI Canadian National $113.77 / +4.28 (+3.91%) CN announced plans to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CNI Canadian National $113.77 / +4.28 (+3.91%) 06/23/22 CN to invest C$160M in Manitoba in 2022 06/23/22 CN to invest C$15M in Nova Scotia in 2022 06/22/22 North American rail traffic fell 2.8% for the week ending June 18 06/22/22 CN to invest C$430M in Ontario in 2022 CNI Canadian National $113.77 / +4.28 (+3.91%) 06/14/22 Deutsche Bank Canadian National named short-term investment idea at Deutsche Bank 06/02/22 CIBC Canadian National upgraded to Outperformer from Neutral at CIBC 05/26/22 Evercore ISI Canadian National upgraded to Outperform from In Line at Evercore ISI 05/19/22 Citi Canadian National price target lowered to $132 from $140 at Citi CNI Canadian National $113.77 / +4.28 (+3.91%) 04/26/22 Canadian National lowers FY22 adjusted EPS view to up 15%-20% from up 20% 04/26/22 Canadian National reports Q1 adjusted EPS C$1.32 vs. C$1.23 last year 01/25/22 Canadian National sees FY22 adjusted EPS up 20% 01/25/22 Canadian National reports Q4 adjusted EPS C$1.71 vs. C$1.43 last year CNI Canadian National $113.77 / +4.28 (+3.91%) 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/22 Fly Intel: After-Hours Movers 07/26/22 Canadian National - CNI CNI Canadian National $113.77 / +4.28 (+3.91%) 01/25/22 Canadian National options imply 3.2% move in share price post-earnings
Hot Stocks	US Foods opens distribution facility in Sacramento, California » 08:08 06/27/22 06/27 08:08 06/27/22 08:08 USFD US Foods $32.00 / +3.54 (+12.44%) US Foods announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly USFD US Foods $32.00 / +3.54 (+12.44%) 06/08/22 Teamsters in negotiations with US Foods say work stoppages 'imminent' 05/18/22 US Foods partners with Kalera to expand fresh produce portfolio 05/12/22 US Foods reaffirms FY22 guidance provided on February 17 05/10/22 US Foods announces transition of CEO Pietro Satriano, affirms FY22 guidance USFD US Foods $32.00 / +3.54 (+12.44%) 06/09/22 Barclays US Foods price target lowered to $34 from $38 at Barclays 05/18/22 Berenberg US Foods initiated with a Buy at Berenberg 05/02/22 CL King US Foods price target raised to $43 from $41 at CL King 04/14/22 Morgan Stanley US Foods price target lowered to $41 from $43 at Morgan Stanley USFD US Foods $32.00 / +3.54 (+12.44%) 05/12/22 US Foods reports Q1 adjusted EPS 36c, consensus 66c 05/11/22 Notable companies reporting before tomorrow's open 05/11/22 Notable companies reporting before tomorrow's open 04/21/22 US Foods reports preliminary Q1 adjusted EPS 36c, consensus 22c USFD US Foods $32.00 / +3.54 (+12.44%) 05/09/22 Sachem Head near deal to get three seats on US Foods board, Bloomberg says 03/16/22 Activist target US Foods mulling changes to board, Reuters reports USFD US Foods $32.00 / +3.54 (+12.44%) 05/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/16/22 What You Missed On Wall Street On Wednesday 03/16/22 What You Missed On Wall Street This Morning 03/14/22 Fly Insider: Ball Corp, Datadog among week's notable insider trades
Hot Stocks	Maravai Lifesciences names Peter Leddy as EVP, CAO » 08:08 06/27/22 06/27 08:08 06/27/22 08:08 MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) Maravai LifeSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) 05/24/22 Maravai's TriLink BioTechnologies announces cooperative agreement with DoD 04/07/22 Maravai Lifesciences up 5% in afternoon trading after Betaville rumor mention 02/25/22 Maravai Lifesciences up 10% after Reuters says rejected $42 per share bid 01/28/22 Maravai Lifesciences acquires MyChem for $240M in cash MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) 05/06/22 Baird Maravai Lifesciences price target lowered to $40 from $48 at Baird 02/28/22 William Blair Maravai buyout price would need to be well into $50s, says William Blair 02/24/22 Baird Maravai Lifesciences price target lowered to $48 from $60 at Baird 10/01/21 Morgan Stanley Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) 02/23/22 Maravai Lifesciences sees FY22 revenue $920M-$960M, consensus $863.92M 02/23/22 Maravai Lifesciences reports Q4 EPS 42c, consensus 38c 10 Sep MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says 02/25/22 Maravai rejected Sartorius $42 per share bid as too low, Reuters says MRVI Maravai Lifesciences $28.46 / +0.47 (+1.68%) 02/25/22 What You Missed On Wall Street On Friday

Hot Stocks	Analog Devices appoints Andonian to board of directors » 08:07 06/27/22 06/27 08:07 06/27/22 08:07 ADI Analog Devices $149.69 / +4.12 (+2.83%) Analog Devices announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ADI Analog Devices $149.69 / +4.12 (+2.83%) 06/21/22 Analog Devices director buys $526.2K in common stock 05/23/22 Synopsys, Analog Devices announce collaboration 03/28/22 Ambarella hires new CFO, Brian White, formerly with Maxim Integrated Products 03/28/22 Analog Devices, Gridspertise team on smart grid resiliency, electrification ADI Analog Devices $149.69 / +4.12 (+2.83%) 06/06/22 Citi Citi says semi stocks could fall another 30%, names new top pick 06/05/22 Citi Analog Devices named a Top Pick at Citi 06/01/22 BofA BofA sees 'compelling' valuations in semis, names top picks 05/20/22 Daiwa Daiwa sees six month 'danger zone' for semiconductor stocks ADI Analog Devices $149.69 / +4.12 (+2.83%) 05/18/22 Analog Devices sees Q3 adjusted EPS $2.42 +/- 10c, consensus $2.16 05/18/22 Analog Devices reports Q2 adjusted EPS $2.40, consensus $2.11 04/05/22 Analog Devices sees long-term revenue growth CAGR 7%-10% 04/05/22 Analog Devices sees path to $15 of EPS, 40% free cash flow by 2027 ADI Analog Devices $149.69 / +4.12 (+2.83%) 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning 05/18/22 Fly Intel: Pre-market Movers 04/11/22 Fly Insider: Icosavax, Analog Devices among week's notable insider trades ADI Analog Devices $149.69 / +4.12 (+2.83%) 06/13/22 Analog Devices call volume above normal and directionally bullish 01/18/22 Analog Devices put volume heavy and directionally bearish 01/07/22 Analog Devices put volume heavy and directionally bearish 01/04/22 Analog Devices put volume heavy and directionally bearish
Hot Stocks	Chemomab data supports efficacy of CM-101 in primary sclerosing cholangitis » 08:07 06/27/22 06/27 08:07 06/27/22 08:07 CMMB Chemomab Therapeutics $4.12 / +0.36 (+9.57%) Chemomab Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMMB Chemomab Therapeutics $4.12 / +0.36 (+9.57%) 06/02/22 Chemomab Therapeutics' CM-101 antibody featured in poster presentation at EULAR CMMB Chemomab Therapeutics $4.12 / +0.36 (+9.57%) 03/10/22 Oppenheimer Chemomab Therapeutics price target lowered to $20 from $30 at Oppenheimer 12/07/21 Aegis Chemomab Therapeutics initiated with a Buy at Aegis CMMB Chemomab Therapeutics $4.12 / +0.36 (+9.57%) 05/12/22 Chemomab Therapeutics reports Q1 EPS (2c) vs. (1c) last year 03/09/22 Chemomab Therapeutics reports Q4 EPS (2c), consensus (10c)
Hot Stocks	Kaival: CEO Patel to transition to Chief Science and Regulatory Officer » 08:07 06/27/22 06/27 08:07 06/27/22 08:07 KAVL Kaival Brands $1.72 / -0.07 (-3.91%) , PM Philip Morris $103.37 / +1.695 (+1.67%) Kaival Brands Innovations… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events KAVL PM KAVL Kaival Brands $1.72 / -0.07 (-3.91%) 06/13/22 Kaival Brands, Philip Morris enter agreement for distribution of ENDS products 04/18/22 Kaival Brands expands distribution for Bidi Vapor 02/18/22 Kaival Brands regains compliance with Nasdaq 02/03/22 Kaival Brands: Court grants judicial stay of MDO by FDA to Bidi Vapor PM Philip Morris $103.37 / +1.695 (+1.67%) 06/14/22 Philip Morris expects better performance from core business in Q2 06/13/22 Kaival Brands, Philip Morris enter agreement for distribution of ENDS products 05/11/22 Swedish Match board recommends accepting Philip Morris takeover bid 05/11/22 Philip Morris affiliate offers to buy Swedish Match for SEK 106 per share KAVL PM KAVL Kaival Brands $1.72 / -0.07 (-3.91%) 04/08/22 Maxim Kaival Brands initiated with a Buy at Maxim PM Philip Morris $103.37 / +1.695 (+1.67%) 06/22/22 Jefferies FDA lowered nicotine rule likely to take many years to implement, says Jefferies 06/08/22 Morgan Stanley Morgan Stanley downgrades Altria to Underweight on competition concerns 05/19/22 Jefferies Swedish Match upgraded to Hold from Underperform at Jefferies 05/16/22 UBS Swedish Match downgraded to Neutral from Buy at UBS PM PM Philip Morris $103.37 / +1.695 (+1.67%) 04/21/22 Philip Morris sees FY22 pro forma adjusted EPS ex-currency $5.98-$6.09 04/21/22 Philip Morris reports Q1 adjusted EPS $1.56, consensus $1.49 04/20/22 Notable companies reporting before tomorrow's open 04/20/22 Notable companies reporting before tomorrow's open 30 Sep PM PM Philip Morris $103.37 / +1.695 (+1.67%) 06/21/22 Biden administration plans move to reduce nicotine in cigarettes, WaPo reports 06/15/22 Jury says Reynolds owes Philip Morris $10.76B in e-vapor case, Bloomberg says 05/09/22 Philip Morris in advanced talks to acquire Swedish Match, WSJ reports 05/09/22 Philip Morris in talks to acquire Swedish Match for $15B, WSJ says KAVL PM KAVL Kaival Brands $1.72 / -0.07 (-3.91%) 06/14/22 Fly Intel: Pre-market Movers PM Philip Morris $103.37 / +1.695 (+1.67%) 06/22/22 What You Missed On Wall Street On Wednesday 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/21/22 Philip Morris - PM
Hot Stocks	Biocept appoints RSM as independent auditor » 08:06 06/27/22 06/27 08:06 06/27/22 08:06 BIOC Biocept / + Biocept announces the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BIOC Biocept / + 06/22/22 Plus, Biocept announce laboratory services agreement for ReSPECT-LM Trial 03/08/22 Biocept appoints Philippe Marchand as COO 02/16/22 Biocept trading resumes 02/16/22 Biocept names Riccitelli interim CEO, Morales interim CFO BIOC Biocept / + 10/08/21 Brookline Biocept assumed with a Buy at Brookline BIOC Biocept / + 04/06/22 Biocept reports Q4 EPS (18c) vs. 14c last year 03/31/22 Biocept reports 2021 revenue $61.2M, two estimates $58.39M
Downgrade	4D pharma downgraded to Neutral from Buy at Chardan » 08:06 06/27/22 06/27 08:06 06/27/22 08:06 LBPS 4D pharma $1.65 / +0.04 (+2.48%) Chardan analyst Keay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research LBPS 4D pharma $1.65 / +0.04 (+2.48%) 06/24/22 4D pharma says unable to make repayment of loans demanded by Oxford 06/24/22 4D Pharma PLC (ADS) trading halted, news pending 05/26/22 4D pharma presents Phase 2 data of MRx0518 03/23/22 4D pharma announces results of MRx0518/ Keytruda study for RCC treatment LBPS 4D pharma $1.65 / +0.04 (+2.48%) 06/24/22 Ladenburg 4D pharma downgraded to Neutral from Buy at Ladenburg 03/24/22 Ladenburg 4D pharma price target raised to $37 from $35 at Ladenburg 07/09/21 Chardan 4D pharma assumed with a Buy at Chardan

Hot Stocks	Curaleaf, Fab 5 Freddy expand B NOBLE cannabis brand to New Jersey » 08:05 06/27/22 06/27 08:05 06/27/22 08:05 CURLF Curaleaf $5.18 / +0.07 (+1.37%) B Noble Inc. and Curaleaf… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CURLF Curaleaf $5.18 / +0.07 (+1.37%) 05/26/22 Curaleaf launches Endless Coast Cannabis-Infused Seltzers in Massachusetts 05/09/22 Curaleaf names Matt Darin as CEO, succeeding Joe Bayern 04/29/22 Curaleaf opens two new Florida dispensaries 04/20/22 Curaleaf launches BlueKudu infused chocolates in Florida CURLF Curaleaf $5.18 / +0.07 (+1.37%) 05/10/22 Canaccord Curaleaf price target lowered to C$14.50 from C$15.50 at Canaccord 05/10/22 Stifel Curaleaf price target lowered to C$24 from C$25 at Stifel 03/07/22 Stifel Curaleaf price target lowered to C$25 from C$31 at Stifel 03/04/22 Alliance Global Partners Curaleaf price target lowered to C$15 from C$21 at Alliance Global Partners CURLF Curaleaf $5.18 / +0.07 (+1.37%) 03/04/22 Curaleaf reports Q4 EPS (4c), three estimates (3c) CURLF Curaleaf $5.18 / +0.07 (+1.37%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says CURLF Curaleaf $5.18 / +0.07 (+1.37%) 04/14/22 Here's What You Missed in Cannabis This Week 02/25/22 What You Missed On Wall Street This Morning 02/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/07/22 Rising High: GrowGeneration acquires assets of Mobile Media, MMI
Hot Stocks	Jiuzi Holdings enters into LOI with subsidiary of Baoneng Auto Group » 08:04 06/27/22 06/27 08:04 06/27/22 08:04 JZXN Jiuzi Holdings / + Jiuzi Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly JZXN Jiuzi Holdings / + 06/23/22 Jiuzi Holdings signs purchase order for up to 1,000 electric vehicles 06/22/22 Jiuzi Holdings partners with Chinese car dealer Shuke 05/18/22 Jiuzi Holdings enters strategic cooperation with Chinese EV brand distributor 04/26/22 Jiuzi Holdings announces agreement for 72.05% equity of Huizhou Jiwo JZXN Jiuzi Holdings / + 01/11/22 Wall Street in Fives - Must Read Lists for Tuesday 01/11/22 Wall Street in Fives - Must Read Lists at Midday
Hot Stocks	Cybin receives FDA IND clearance for Phase 1/2a trial evaluating CYB003 » 08:04 06/27/22 06/27 08:04 06/27/22 08:04 CYBN Cybin / + Cybin announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events CYBN Cybin / + 06/09/22 Cybin gets IRB approval for Phase 1/2a clinical trial of CYB003 in MDD 06/07/22 Cybin aquires DMT clinical study from Entheon Biomedical 06/02/22 Cybin announces publication of article on psychedelic-assisted psychotherapy 05/31/22 Cybin submits IND for 1st in human trial for CYB003 in MDD treatment CYBN Cybin / + 06/23/22 Canaccord Cybin undervalued relative to market size opportunity, says Canaccord 06/10/22 Canaccord Cybin shares remain significantly undervalued, says Canaccord 04/13/22 H.C. Wainwright H.C. Wainwright says Cybin preclinical data show continued innovation leadership 11/23/21 Stifel Cybin price target lowered to C$8.25 from C$10 at Stifel 00:00 Today 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics & Beyond
Recommendations	Nio price target lowered to $48 from $55 at Mizuho » 08:04 06/27/22 06/27 08:04 06/27/22 08:04 NIO Nio $24.08 / +1 (+4.33%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NIO Nio $24.08 / +1 (+4.33%) 06/26/22 Fly Intel: Top five weekend stock stories 06/01/22 NIO delivers 7,024 vehicles in May 05/20/22 Nio up 7% in pre-market after company announced Singapore exchange listing 05/05/22 Nio provides update on HFCAA status NIO Nio $24.08 / +1 (+4.33%) 06/21/22 Citi Nio price target lowered to $41.10 from $87 at Citi 06/17/22 Morgan Stanley Nio's recent outperformance has several drivers, says Morgan Stanley 06/15/22 Morgan Stanley Nio's ES7, SUV upgrades should meet expectations, says Morgan Stanley 06/15/22 Mizuho Mizuho likes three electric vehicle stocks into second half rebound NIO Nio $24.08 / +1 (+4.33%) 06/09/22 Nio sees Q2 revenue $1.473B-$1.591B, consensus $1.86B 06/09/22 Nio reports Q1 adjusted EPS (13c), consensus (13c) 06/08/22 Notable companies reporting before tomorrow's open 03/24/22 Nio sees Q1 revenue $1.51B-$1.57B, consensus $1.66B NIO Nio $24.08 / +1 (+4.33%) 06/25/22 Lucid stock looks more vulnerable than Tesla, other peers, Barron's says 06/10/22 Nio to start making self-developed battery packs in 2024, Reuters says 06/06/22 Nio looking to hire professionals to build U.S. plant, DigiTimes reports 05/31/22 Nio may look to set up production in U.S., DigiTimes reports NIO Nio $24.08 / +1 (+4.33%) 06/13/22 What You Missed This Week in EVs and Clean Energy 06/10/22 What You Missed On Wall Street On Friday 06/10/22 What You Missed On Wall Street This Morning 06/09/22 What You Missed On Wall Street On Thursday NIO Nio $24.08 / +1 (+4.33%) 06/15/22 Notable open interest changes for June 15th 06/09/22 Unusually active option classes on open June 9th 06/01/22 NIO call volume above normal and directionally bullish 06/01/22 Unusually active option classes on open June 1st
Hot Stocks	Inovio names Michael Sumner as chief medical officer » 08:04 06/27/22 06/27 08:04 06/27/22 08:04 INO Inovio $1.93 / -0.07 (-3.51%) INOVIO announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options INO Inovio $1.93 / -0.07 (-3.51%) 05/27/22 Inovio announces survival results from trial of INO-5401+INO-9012+Libtayo 05/10/22 Inovio names Jacqueline Shea, Ph.D., as CEO, succeeding Dr. J. Joseph Kim 03/02/22 Inovio under pressure on COVID vaccine trial endpoint switch INO Inovio $1.93 / -0.07 (-3.51%) 05/11/22 Oppenheimer Oppenheimer downgrades Inovio to Perform as lead projects stumble, CEO departs 05/11/22 Oppenheimer Inovio downgraded to Perform from Outperform at Oppenheimer 05/11/22 Cantor Fitzgerald Inovio price target lowered to $3 from $6 at Cantor Fitzgerald 01/21/22 BofA Inovio upgraded to Neutral at BofA on valuation, COVID vaccine viability INO Inovio $1.93 / -0.07 (-3.51%) 05/10/22 Inovio reports Q1 EPS (36c), consensus (34c) 03/01/22 Inovio reports Q4 EPS (50c), consensus (32c) INO Inovio $1.93 / -0.07 (-3.51%) 05/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/02/22 What You Missed On Wall Street On Wednesday 03/02/22 What You Missed On Wall Street This Morning 12/29/21 Wall Street in Fives - Must Read Lists for Wednesday INO Inovio $1.93 / -0.07 (-3.51%) 05/23/22 Unusually active option classes on open May 23rd 12/27/21 Inovio call volume above normal and directionally bullish

Recommendations	Rivian Automotive price target lowered to $70 from $80 at Mizuho » 08:04 06/27/22 06/27 08:04 06/27/22 08:04 RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 06/26/22 Fly Intel: Top five weekend stock stories 06/06/22 Rivian says roadmap focused so cash can support 2025 launch of R2 platform 06/06/22 Rivian Automotive to host first annual shareholder meeting 05/31/22 Rivian Automotive director buys $1.17M in common stock RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 06/15/22 Mizuho Mizuho likes three electric vehicle stocks into second half rebound 06/06/22 Deutsche Bank Tesla workforce reduction 'direct warning' to industry, says Deutsche Bank 06/01/22 DA Davidson DA Davidson starts Rivian Automotive with sell on headline worries 06/01/22 DA Davidson Rivian Automotive initiated with an Underperform at DA Davidson RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 05/11/22 Rivian Automotive reports Q1 adjusted EPS ($1.43), consensus ($1.44) 05/11/22 Notable companies reporting after market close 04/28/22 Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36 03/10/22 Rivian sees FY22 adjusted EBITDA ($4.75B) 10 Nov RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 06/26/22 Tesla. Ford and GM raise EV prices as costs and demand grow, WSJ reports 06/25/22 Lucid stock looks more vulnerable than Tesla, other peers, Barron's says 06/14/22 Tesla CEO says rivals Rivian, Lucid 'tracking toward bankruptcy,' Electrek says 06/08/22 Lucid, Rivian awarded CEOs over $400M in pay last year, WSJ reports RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 06/13/22 What You Missed This Week in EVs and Clean Energy 06/06/22 What You Missed This Week in EVs and Clean Energy 05/31/22 What You Missed On Wall Street This Morning 05/31/22 What You Missed This Week in EVs and Clean Energy RIVN Rivian Automotive $29.52 / +0.06 (+0.20%) 06/21/22 Rivian call volume above normal and directionally bullish 05/24/22 Rivian put volume heavy and directionally bearish 05/18/22 Rivian call volume above normal and directionally bullish 05/12/22 Notable open interest changes for May 12th
Recommendations	Tesla price target lowered to $1,150 from $1,300 at Mizuho » 08:03 06/27/22 06/27 08:03 06/27/22 08:03 TSLA Tesla $737.59 / +31.915 (+4.52%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSLA Tesla $737.59 / +31.915 (+4.52%) 06/26/22 Fly Intel: Top five weekend stock stories 06/23/22 Tesla, PG&E partner over virtual power plant 06/21/22 Twitter board unanimously recommends shareholders vote for deal with Musk 06/16/22 Cathie Wood's ARK Investment bought 5.2K shares of Tesla today TSLA Tesla $737.59 / +31.915 (+4.52%) 06/24/22 Credit Suisse Credit Suisse cuts Tesla cut, sees Q2 deliveries below consensus 06/22/22 Morgan Stanley Tesla price target lowered to $1,200 from $1,300 at Morgan Stanley 06/15/22 Mizuho Mizuho likes three electric vehicle stocks into second half rebound 06/14/22 Morgan Stanley Morgan Stanley says 'very prudent' to shift some Tesla production to Q3 from Q2 TSLA Tesla $737.59 / +31.915 (+4.52%) 04/20/22 Tesla reports Q1 EPS $3.22, consensus $2.26 04/20/22 Notable companies reporting after market close 01/26/22 Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26 01/26/22 Notable companies reporting after market close TSLA Tesla $737.59 / +31.915 (+4.52%) 06/26/22 Tesla. Ford and GM raise EV prices as costs and demand grow, WSJ reports 06/25/22 Lucid stock looks more vulnerable than Tesla, other peers, Barron's says 06/23/22 Tesla expands availability of Model Y, increases prices, Electrek reports 06/22/22 Tesla CEO said in interview Texas and Berlin plants 'losing billions,' AN says TSLA Tesla $737.59 / +31.915 (+4.52%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/23/22 What You Missed On Wall Street This Morning 06/22/22 What You Missed On Wall Street On Wednesday 08/04/22 Tesla, Inc. TSLA Tesla $737.59 / +31.915 (+4.52%) 06/23/22 Notable open interest changes for June 23rd 06/22/22 Notable open interest changes for June 22nd 06/21/22 Early notable gainers among liquid option names on June 21st 06/21/22 Notable open interest changes for June 21st
Hot Stocks	CECO Environmental completes acquisiton of Western Air Ducts » 08:03 06/27/22 06/27 08:03 06/27/22 08:03 CECE CECO Environmental $6.03 / +0.09 (+1.52%) CECO Environmental… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CECE CECO Environmental $6.03 / +0.09 (+1.52%) 05/10/22 CECO Environmental announces $20M share repurchase program 05/10/22 CECO Environmental acquires Compass Water Solutions for $12.5M 04/07/22 CECO Environmental acquires Index Water 02/14/22 CECO Environmental receives order for exhaust systems in Australia CECE CECO Environmental $6.03 / +0.09 (+1.52%) 04/29/22 Lake Street CECO Environmental initiated with a Buy at Lake Street CECE CECO Environmental $6.03 / +0.09 (+1.52%) 03/14/22 CECO Environmental CEO sees 'double-digit EBITDA growth in 2022' 03/14/22 CECO Environmental reports Q4 adjusted EPS 10c, consensus 8c
Hot Stocks	Axsome Therapeutics reports receipt from FDA of proposed AXS-05 labeling » 08:03 06/27/22 06/27 08:03 06/27/22 08:03 AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) Axsome Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) 06/06/22 Axsome Therapeutics announces results of SUPPORT survey of MDD patients 06/02/22 Axsome Therapeutics presents new data from GEMINI trial on AXS-05 06/01/22 Axsome reports rapid, substantial improvement in MADRS, SDS with AXS-05 05/31/22 Axsome Therapeutics announces publication of GEMINI Phase 3 trial of AXS-05 AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) 05/06/22 Morgan Stanley Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news 05/03/22 Mizuho Axsome Therapeutics price target lowered to $49 from $51 at Mizuho 04/19/22 Guggenheim Guggenheim sees 'high likelihood of approval' for Axsome's AXS-05 for MDD 03/29/22 Jefferies Axsome Therapeutics price target raised to $77 from $71 at Jefferies AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) 05/02/22 Axsome Therapeutics reports Q1 EPS ($1.03) with items, consensus (10c) 03/01/22 Axsome Therapeutics reports Q4 EPS (90c), consensus ($1.03) AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) 04/25/22 What You Missed On Wall Street On Monday 04/25/22 What You Missed On Wall Street This Morning 04/25/22 Fly Intel: Pre-market Movers 04/19/22 What You Missed On Wall Street On Tuesday AXSM Axsome Therapeutics $24.45 / -0.27 (-1.09%) 06/24/22 Axsome Therapeutics put volume heavy and directionally bearish 06/23/22 Axsome Therapeutics call volume above normal and directionally bullish 04/22/22 Axsome Therapeutics put volume heavy and directionally bearish 12/27/21 Unusually active option classes on open December 27th
Hot Stocks	UpHealth announces delay of annual meeting » 08:02 06/27/22 06/27 08:02 06/27/22 08:02 UPH UpHealth / + UpHealth issued the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events UPH UpHealth / + 06/14/22 UpHealth announces removal of Chirinjeev Kathuria as co-chairman of the board 06/10/22 UpHealth stockholders urge other stockholders not to return white proxy card 05/12/22 UpHealth names Samuel Meckey as new CEO 04/14/22 UpHealth's Florida mental health facility partners with Blue Cross Blue Shield UPH UpHealth / + 05/13/22 Benchmark UpHealth price target lowered to $4 from $5 at Benchmark 03/31/22 Lake Street Lake Street downgrades UpHealth to Hold, thinks credibility must be rebuilt 03/31/22 Northland UpHealth price target lowered to $4.50 from $10.50 at Northland 03/31/22 Lake Street UpHealth downgraded to Hold from Buy at Lake Street UPH UpHealth / + 04/18/22 UpHealth sees FY22 revenue $205M-$233M, consensus $205.23M 04/18/22 UpHealth reports Q4 EPS (3c), consensus (17c) 03/30/22 UpHealth sees 2022 revenue $205M-$233M, consensus $273.58M 03/30/22 UpHealth sees Q4 revenue $33.9M-$41.7M, consensus $60.66M 05 Oct UPH UpHealth / + 04/18/22 What You Missed On Wall Street On Monday 04/18/22 What You Missed On Wall Street This Morning 04/18/22 Fly Intel: Pre-market Movers 03/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/28/22 UpHealth Inc

Hot Stocks	Zivo Bioscience joins Russell Microcap Index » 08:02 06/27/22 06/27 08:02 06/27/22 08:02 ZIVO Zivo Bioscience $3.51 / +0.52 (+17.39%) ZIVO Bioscience announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ZIVO Zivo Bioscience $3.51 / +0.52 (+17.39%) 04/25/22 Zivo Bioscience regains Nasdaq compliance 01/10/22 Zivo Bioscience names Chairman John Payne as President and CEO ZIVO Zivo Bioscience $3.51 / +0.52 (+17.39%) 12/15/21 Maxim Zivo Bioscience initiated with a Buy at Maxim 12/15/21 Maxim Zivo Bioscience initiated with a Buy at Maxim
Recommendations	Consolidated Edison price target lowered to $99 from $100 at Mizuho » 08:01 06/27/22 06/27 08:01 06/27/22 08:01 ED Consolidated Edison $92.93 / +1.615 (+1.77%) Mizuho analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ED Consolidated Edison $92.93 / +1.615 (+1.77%) 01/20/22 Consolidated Edison raises annual dividend to $3.16 from $3.10 per share 12/30/21 W.Va regulators issue water quality certification for Mountain Valley Pipeline ED Consolidated Edison $92.93 / +1.615 (+1.77%) 05/23/22 Guggenheim Guggenheim ups Consolidated Edison to Neutral with regulatory risks subsiding 05/23/22 Guggenheim Consolidated Edison upgraded to Neutral from Sell at Guggenheim 05/03/22 Wells Fargo Wells Fargo downgrades Consolidated Edison to sell on 'tricky' NY rate case 05/02/22 Wells Fargo Consolidated Edison downgraded to Underweight from Equal Weight at Wells Fargo ED Consolidated Edison $92.93 / +1.615 (+1.77%) 05/05/22 Consolidated Edison backs FY22 EPS view of $4.40-$4.60, consensus $4.49 05/05/22 Consolidated Edison reports Q1 EPS $1.47, consensus $1.48 02/17/22 Consolidated Edison reports Q4 operating revenue $3.42B, consensus $2.76B 02/17/22 Consolidated Edison sees FY22 adjusted EPS $4.40-$4.60, consensus $4.48 ED Consolidated Edison $92.93 / +1.615 (+1.77%) 06/16/22 ConEd working with Barclays on $4B clean energy sale, Bloomberg says 06/16/22 ConEd working with Barclays on $4B clean energy sale, Bloomberg says
Hot Stocks	Nikola urges shareholders to vote for Proposal 2 » 08:01 06/27/22 06/27 08:01 06/27/22 08:01 NKLA Nikola $5.61 / -0.06 (-1.06%) Nikola Corporation urges… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKLA Nikola $5.61 / -0.06 (-1.06%) 06/09/22 Nikola's Tre BEV approved for New York Truck Voucher Incentive Program 06/07/22 Nikola urges stockholders to vote "FOR" each proposal at annual meeting 05/11/22 Volkswagen Group to launch all-electric pick-up and 'rugged' SUV in U.S 05/05/22 Nikola provides 2022 outlook NKLA Nikola $5.61 / -0.06 (-1.06%) 05/10/22 Wedbush Nikola price target lowered to $10 from $15 at Wedbush 03/25/22 Wedbush Nikola's analyst day sets bullish tone for 2022, beyond, says Wedbush 03/24/22 Deutsche Bank Deutsche Bank left Nikola analyst day 'highly encouraged' 03/10/22 JPMorgan Nikola is tracking to 2022 goals, says JPMorgan NKLA Nikola $5.61 / -0.06 (-1.06%) 05/05/22 Nikola reports Q1 adjusted EPS (21c), consensus (27c) 05/04/22 Notable companies reporting before tomorrow's open 05/04/22 Notable companies reporting before tomorrow's open 02/24/22 Nikola reports Q4 adjusted EPS (23c), consensus (32c) NKLA Nikola $5.61 / -0.06 (-1.06%) 06/23/22 Nikola founder Milton faces additional wire fraud charge, Reuters reports 02/09/22 Nikola responds to report on losing supply chain executives, Reuters reports 02/08/22 Nikola loses supply chain executives and implements hiring freeze, Electrek says 01/10/22 Rivian COO leaves amid December's production ramp, WSJ reports NKLA Nikola $5.61 / -0.06 (-1.06%) 05/04/22 Here's what Wall Street experts are saying about these EV names ahead of results 04/23/22 Short Report: Stitch Fix bears gnawing on shares 03/26/22 Short Report: GameStop, Bed Bath Beyond activity altered by Ryan Cohen 03/24/22 What You Missed On Wall Street On Thursday 06/30/22 Nikola Corporation NKLA Nikola $5.61 / -0.06 (-1.06%) 06/08/22 Nikola call volume above normal and directionally bullish 06/03/22 Notable open interest changes for June 3rd 06/02/22 Unusually active option classes on open June 2nd 05/27/22 Notable open interest changes for May 27th
Options	Apple call buyer realizes 8% same-day gains » 08:00 06/27/22 06/27 08:00 06/27/22 08:00 AAPL Apple $141.87 / +3.61 (+2.61%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AAPL Apple $141.87 / +3.61 (+2.61%) 06/19/22 Apple store workers in Maryland vote to form first U.S. union 06/14/22 Apple says new 13-inch MacBook Pro available to order starting June 17 06/14/22 Apple announces partnership to present Major League Soccer matches 06/12/22 Fly Intel: Top five weekend stock stories AAPL Apple $141.87 / +3.61 (+2.61%) 07:05 Today Bernstein Apple TV+ may have 20M-40M paying subscribers, says Bernstein 06/23/22 Bernstein Bernstein worries Apple EPS estimates for 2023 may be too high 06/22/22 BofA Apple App Store growth up 6% in fiscal Q3-to-date, says BofA 06/21/22 UBS Apple iPhone shipments in China post 'strong rebound', says UBS AAPL Apple $141.87 / +3.61 (+2.61%) 04/28/22 Apple says y/y Q3 revenue growth to be impacted by COVID 04/28/22 Apple reports Q2 EPS $1.52, consensus $1.43 04/28/22 Notable companies reporting after market close 02/27/22 Berkshire operating earnings surge, Buffett repurchases record $27B in stock AAPL Apple $141.87 / +3.61 (+2.61%) 05:47 Today Apple embarking on 'ambitious' period of products, Bloomberg's Gurman reports 06/24/22 Disney, Apple, Amazon bid on NFL's Sunday Ticket, CNBC reports 06/24/22 Analyst says Apple likely to unveil AR/MR headset in January, 9to5Mac says 06/17/22 TSMC to start 2nm processor production by 2025, Nikkei Asia reports AAPL Apple $141.87 / +3.61 (+2.61%) 06/15/22 #SocialStocks: Elon Musk set to address Twitter employees 06/14/22 What You Missed On Wall Street On Tuesday 06/13/22 What You Missed On Wall Street On Monday 06/13/22 What You Missed On Wall Street This Morning AAPL Apple $141.87 / +3.61 (+2.61%) 06/24/22 Notable open interest changes for June 24th 06/23/22 Notable open interest changes for June 23rd 06/22/22 Notable open interest changes for June 22nd 06/21/22 Notable open interest changes for June 21st
Hot Stocks	Stealth BioTherapeutics Corporation (ADS) trading resumes 08:00 06/27/22 06/27 08:00 06/27/22 08:00 MITO Stealth Biotherapeutics / + ShowHide Related Items >><< Company News Street Research Earnings MITO Stealth Biotherapeutics / + 07:28 Today Stealth BioTherapeutics Corporation (ADS) trading halted, news pending 06/14/22 Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide 06/08/22 Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study 05/31/22 Stealth granted orphan drug designation for elamipretide by EMA MITO Stealth Biotherapeutics / + 05/23/22 H.C. Wainwright Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim MITO Stealth Biotherapeutics / + 07:34 Today Stealth Biotherapeutics announces receipt of preliminary non-binding proposal

Events

Earnings calls, analyst events, roadshows and more

THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls
Today at 13:00

Healthcare Facilities & Managed Care Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

AstraZeneca reports Evusheld recommended for approval in EU for COVID prevention

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access